2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Insurance Revenue | -- | -- | -- | -- | -- | -- |
Interest Income | -- | -- | -- | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | 457,203,000 | 7.741% | 424,355,000 | 449,533,000 | 433,187,000 | 433,175,000 |
Net Premium Income | 451,061,000 | 7.816% | 418,362,000 | 396,997,000 | 393,127,000 | 380,683,000 |
Investment Income/(Loss) | 15,787,000 | -1.171% | 15,974,000 | 17,996,000 | 17,709,000 | 16,986,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | 4,380,000 | 4,583,000 | 1,403,000 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | (746,000) | (3,063,000) | (670,000) |
Other Income/(Loss) | 306,000 | -83.214% | 1,823,000 | 624,000 | 0 | 431,000 |
Total Revenues | 467,154,000 | 7.106% | 436,159,000 | 419,251,000 | 412,356,000 | 398,833,000 |
Insurance Service Expenses | -- | -- | -- | -- | -- | -- |
Net Expenses from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (444,649,000) | 9.273% | (406,916,000) | (397,747,000) | (391,631,000) | (379,300,000) |
Other Non-operating Items | -- | -- | -- | 0 | 0 | 0 |
Share of results of Associates & JCEs | 5,530,000 | 15.763% | 4,777,000 | 4,524,000 | 3,951,000 | 4,250,000 |
Profit / (Loss) before Taxation | 28,035,000 | -17.593% | 34,020,000 | 26,028,000 | 24,676,000 | 23,783,000 |
Taxation | (3,469,000) | -29.377% | (4,912,000) | (3,663,000) | (3,808,000) | 496,000 |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | 19,000 | -65.455% | 55,000 | (5,000) | 0 | 3,000 |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 24,585,000 | -15.698% | 29,163,000 | 22,360,000 | 20,868,000 | 24,282,000 |
2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
Depreciation & Amortisation | 3,750,000 | 0.888% | 3,717,000 | 3,496,000 | 3,539,000 | 3,334,000 |
Directors' Emoluments | -- | -- | 3,503 | 3,294 | 4,281 | 4,742 |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 110.500 | -15.713% | 131.100 | 100.500 | 93.800 | 109.200 |
DPS (cts) | 48.900 | -- | 47.800 | 40.700 | 37.500 | 46.100 |
Dividend Payout Ratio (%) | 44.253% | -- | 36.461% | 40.498% | 39.979% | 42.216% |
Cash flow per share ($) | 0.924 | -- | 1.920 | 0.734 | 0.576 | 1.160 |
NBV per share ($) | 10.404 | -- | 9.833 | 9.121 | 8.430 | 7.641 |
Remarks: | Real time quote last updated: 23/08/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K¥) | RMB 24,585,000 |
%Change | -15.698% |
EPS / (LPS) | RMB 1.105 |
NBV Per Share (¥) | RMB 10.404 |